Drug Carrier

The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2 infection upon the recognition of COVID-19...

Tuberculosis (TB) has been the most life-threatening contagious disease caused by pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 estimated that...

Background: Felodipine is BCS class II drug with poor and variable bioavailability due to its insolubility in water (19mg/L) and extensive...

The interest in the low energy self-emulsification techniques has exploded in the recent years, driven by three main trends: by...

Fused deposition modelling (FDM) 3D printing provides the ability to address individual patients’ therapeutic needs without having to change the...

Flutamide which is used to treat prostate cancer and other diseases induces liver damage during and after the therapy. The aim...

The use of therapeutic proteins and peptides is of great interest for the treatment of many diseases, and advances in...

The use of chemotherapeutic agents such as docetaxel (DTX) in anticancer therapy is often correlated to side effects and the...

Co-amorphous supersaturated drug delivery systems are emerging as an alternative strategy to improve the water solubility of BCS II drugs....

Flufenamic acid (FFA) is a non-steroidal anti-inflammatory drug characterised by a low solubility and problems of variable dissolution rate and...